Globe Life Inc. GL
Composite 63/100; the shares have moved about 22% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Income ranks 41/100 — a slight mark against it.
Momentum ranks 71/100 — a moderate point in its favour. Valuation ranks 71/100 — a moderate point in its favour. Quality ranks 66/100 — a moderate point in its favour.
Income ranks 41/100 — a slight mark against it. Growth ranks 49/100 — a slight mark against it.
What the company does Globe Life Inc. provides life and supplemental health insurance products to lower middle- and middle-income families in the U.S. Its segments include Life Insurance, Supplemental Health Insurance, and Investments, offering whole, term, and children’s life policies, Medicare supplements, accident, cancer, and critical illness coverage, and final expense products.
Key financials ROE 20.9%, ROA 3.4%, gross margin 33.9%, operating margin 24.6%, net margin 19.6%. Revenue growth 3.8%, EPS growth 13.7%. Debt/Equity 0.56, current ratio 0.80. Dividend yield 0.8%, payout 7.9%.
Stock health Overall Sideravia score 63.4 (average quality, attractively valued, positive momentum). Quality 65.9, Growth 53.2, Momentum 72.8. Piotroski F-Score 8/9. 3m momentum 14.62%, 12m 27.10%, RSI(14) 36.10.
Price vs fair value The stock trades at a discount of 13.10% versus the analyst mean target of 193.91. - Globe Life lags industry and trades at a discount (Zacks) - Bigger buyback amid weaker margins altering the investment case (Simply Wall St.) - Could be 5% below fair value after mixed Q2 earnings (Simply Wall St.)
Looking forward Forward P/E 11.67, EV/EBITDA 9.61. Analysts note mixed Q2 earnings and margin pressure despite buybacks. Momentum remains positive but RSI suggests near-term caution.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.